Sign up to save your podcasts
Or
Share Cell Therapy For Corneal Endothelial Dystrophies With Aurion Biotech's Greg Kunst
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Cell Therapy For Corneal Endothelial Dystrophies With Aurion Biotech's Greg Kunst
We love to hear from our listeners. Send us a message.
For this third and final episode recorded at ARM's 2023 Meeting on the Mesa, Cell & Gene: The Podcast Host, Erin Harris, sat down with Greg Kunst, president, CEO, and Board member at Aurion Biotech. Listen in as they discuss the cell therapy used to treat corneal endothelial disease and how Greg navigated the event as a first-timer attending Meeting on the Mesa.
Subscribe to the podcast!
Apple | Spotify | YouTube
View all episodes
By Erin Harris
4.9
3838 ratings
We love to hear from our listeners. Send us a message.
For this third and final episode recorded at ARM's 2023 Meeting on the Mesa, Cell & Gene: The Podcast Host, Erin Harris, sat down with Greg Kunst, president, CEO, and Board member at Aurion Biotech. Listen in as they discuss the cell therapy used to treat corneal endothelial disease and how Greg navigated the event as a first-timer attending Meeting on the Mesa.
Subscribe to the podcast!
Apple | Spotify | YouTube
More shows like Cell & Gene: The Podcast
View all
Nature Podcast
765 Listeners
Science Magazine Podcast
807 Listeners
Economist Podcasts
4,256 Listeners
Freakonomics Radio
32,030 Listeners
The Long Run with Luke Timmerman
124 Listeners
Immune
271 Listeners
The Readout Loud
318 Listeners
FT News Briefing
697 Listeners
Business Of Biotech
88 Listeners
BioCentury This Week
31 Listeners
Raising Health
147 Listeners
Biotech Hangout
11 Listeners
ASGCT Podcast Network
15 Listeners
Elon, Inc.
149 Listeners
Ground Truths
48 Listeners